Advanced Drug Delivery refers to the formulations, systems and technologies for transporting a pharmaceutical compound in the body as it is needed to safely achieve its desired therapeutic effects. Drug delivery systems (DDS), are based on approaches that are interdisciplinary and that combine pharmaceutics, bio conjugate chemistry, and molecular biology.
Market Analysis and Insights: Global Advanced Drug Delivery Market
The global Advanced Drug Delivery market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The Global Advanced Drug Delivery Market is poised to grow at a CAGR of around 7.8% over the next decade to reach approximately $340 billion by 2025. Some of the prominent trends that the market is witnessing include growing focus on unmet medical requirements, increasing demand for generic drugs and biosimilars, rising familiarities of chronic diseases and recent technological developments of advanced drug delivery.
Report Includes
This report presents an overview of global market for Advanced Drug Delivery market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Advanced Drug Delivery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Advanced Drug Delivery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Advanced Drug Delivery revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Advanced Drug Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Advanced Drug Delivery revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck & Co, Antares Pharma, F. Hoffmann-La Roche, Novartis, Bayer, Sanofi, Glaxosmithkline, 3M and Pfizer, etc.
By Company
Merck & Co
Antares Pharma
F. Hoffmann-La Roche
Novartis
Bayer
Sanofi
Glaxosmithkline
3M
Pfizer
Johnson & Johnson
Abbott Laboratories
Allergan
Baxter International
Mylan Pharmaceutical
Roche Holding
Segment by Type
Polymeric Drug Delivery
Implants & IUD's
Sustained Release
Targeted Drug Delivery
Prodrugs
Segment by Application
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers/Clinics
Home Care Settings
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Advanced Drug Delivery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Advanced Drug Delivery companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Advanced Drug Delivery revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Advanced Drug Delivery Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Polymeric Drug Delivery
1.2.3 Implants & IUD's
1.2.4 Sustained Release
1.2.5 Targeted Drug Delivery
1.2.6 Prodrugs
1.3 Market by Application
1.3.1 Global Advanced Drug Delivery Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Ambulatory Surgical Centers/Clinics
1.3.5 Home Care Settings
1.3.6 Other End Users
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Advanced Drug Delivery Market Perspective (2018-2029)
2.2 Global Advanced Drug Delivery Growth Trends by Region
2.2.1 Advanced Drug Delivery Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Advanced Drug Delivery Historic Market Size by Region (2018-2023)
2.2.3 Advanced Drug Delivery Forecasted Market Size by Region (2024-2029)
2.3 Advanced Drug Delivery Market Dynamics
2.3.1 Advanced Drug Delivery Industry Trends
2.3.2 Advanced Drug Delivery Market Drivers
2.3.3 Advanced Drug Delivery Market Challenges
2.3.4 Advanced Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Advanced Drug Delivery by Players
3.1.1 Global Advanced Drug Delivery Revenue by Players (2018-2023)
3.1.2 Global Advanced Drug Delivery Revenue Market Share by Players (2018-2023)
3.2 Global Advanced Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Advanced Drug Delivery, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Advanced Drug Delivery Market Concentration Ratio
3.4.1 Global Advanced Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Advanced Drug Delivery Revenue in 2022
3.5 Global Key Players of Advanced Drug Delivery Head office and Area Served
3.6 Global Key Players of Advanced Drug Delivery, Product and Application
3.7 Global Key Players of Advanced Drug Delivery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Advanced Drug Delivery Breakdown Data by Type
4.1 Global Advanced Drug Delivery Historic Market Size by Type (2018-2023)
4.2 Global Advanced Drug Delivery Forecasted Market Size by Type (2024-2029)
5 Advanced Drug Delivery Breakdown Data by Application
5.1 Global Advanced Drug Delivery Historic Market Size by Application (2018-2023)
5.2 Global Advanced Drug Delivery Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Advanced Drug Delivery Market Size (2018-2029)
6.2 North America Advanced Drug Delivery Market Size by Type
6.2.1 North America Advanced Drug Delivery Market Size by Type (2018-2023)
6.2.2 North America Advanced Drug Delivery Market Size by Type (2024-2029)
6.2.3 North America Advanced Drug Delivery Market Share by Type (2018-2029)
6.3 North America Advanced Drug Delivery Market Size by Application
6.3.1 North America Advanced Drug Delivery Market Size by Application (2018-2023)
6.3.2 North America Advanced Drug Delivery Market Size by Application (2024-2029)
6.3.3 North America Advanced Drug Delivery Market Share by Application (2018-2029)
6.4 North America Advanced Drug Delivery Market Size by Country
6.4.1 North America Advanced Drug Delivery Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Advanced Drug Delivery Market Size by Country (2018-2023)
6.4.3 North America Advanced Drug Delivery Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Advanced Drug Delivery Market Size (2018-2029)
7.2 Europe Advanced Drug Delivery Market Size by Type
7.2.1 Europe Advanced Drug Delivery Market Size by Type (2018-2023)
7.2.2 Europe Advanced Drug Delivery Market Size by Type (2024-2029)
7.2.3 Europe Advanced Drug Delivery Market Share by Type (2018-2029)
7.3 Europe Advanced Drug Delivery Market Size by Application
7.3.1 Europe Advanced Drug Delivery Market Size by Application (2018-2023)
7.3.2 Europe Advanced Drug Delivery Market Size by Application (2024-2029)
7.3.3 Europe Advanced Drug Delivery Market Share by Application (2018-2029)
7.4 Europe Advanced Drug Delivery Market Size by Country
7.4.1 Europe Advanced Drug Delivery Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Advanced Drug Delivery Market Size by Country (2018-2023)
7.4.3 Europe Advanced Drug Delivery Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Advanced Drug Delivery Market Size (2018-2029)
8.2 China Advanced Drug Delivery Market Size by Type
8.2.1 China Advanced Drug Delivery Market Size by Type (2018-2023)
8.2.2 China Advanced Drug Delivery Market Size by Type (2024-2029)
8.2.3 China Advanced Drug Delivery Market Share by Type (2018-2029)
8.3 China Advanced Drug Delivery Market Size by Application
8.3.1 China Advanced Drug Delivery Market Size by Application (2018-2023)
8.3.2 China Advanced Drug Delivery Market Size by Application (2024-2029)
8.3.3 China Advanced Drug Delivery Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Advanced Drug Delivery Market Size (2018-2029)
9.2 Asia Advanced Drug Delivery Market Size by Type
9.2.1 Asia Advanced Drug Delivery Market Size by Type (2018-2023)
9.2.2 Asia Advanced Drug Delivery Market Size by Type (2024-2029)
9.2.3 Asia Advanced Drug Delivery Market Share by Type (2018-2029)
9.3 Asia Advanced Drug Delivery Market Size by Application
9.3.1 Asia Advanced Drug Delivery Market Size by Application (2018-2023)
9.3.2 Asia Advanced Drug Delivery Market Size by Application (2024-2029)
9.3.3 Asia Advanced Drug Delivery Market Share by Application (2018-2029)
9.4 Asia Advanced Drug Delivery Market Size by Region
9.4.1 Asia Advanced Drug Delivery Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Advanced Drug Delivery Market Size by Region (2018-2023)
9.4.3 Asia Advanced Drug Delivery Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Advanced Drug Delivery Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Advanced Drug Delivery Market Size by Type
10.2.1 Middle East, Africa, and Latin America Advanced Drug Delivery Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Advanced Drug Delivery Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Advanced Drug Delivery Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Advanced Drug Delivery Market Size by Application
10.3.1 Middle East, Africa, and Latin America Advanced Drug Delivery Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Advanced Drug Delivery Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Advanced Drug Delivery Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Advanced Drug Delivery Market Size by Country
10.4.1 Middle East, Africa, and Latin America Advanced Drug Delivery Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Advanced Drug Delivery Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Advanced Drug Delivery Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck & Co
11.1.1 Merck & Co Company Details
11.1.2 Merck & Co Business Overview
11.1.3 Merck & Co Advanced Drug Delivery Introduction
11.1.4 Merck & Co Revenue in Advanced Drug Delivery Business (2018-2023)
11.1.5 Merck & Co Recent Developments
11.2 Antares Pharma
11.2.1 Antares Pharma Company Details
11.2.2 Antares Pharma Business Overview
11.2.3 Antares Pharma Advanced Drug Delivery Introduction
11.2.4 Antares Pharma Revenue in Advanced Drug Delivery Business (2018-2023)
11.2.5 Antares Pharma Recent Developments
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Advanced Drug Delivery Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Advanced Drug Delivery Business (2018-2023)
11.3.5 F. Hoffmann-La Roche Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Advanced Drug Delivery Introduction
11.4.4 Novartis Revenue in Advanced Drug Delivery Business (2018-2023)
11.4.5 Novartis Recent Developments
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Advanced Drug Delivery Introduction
11.5.4 Bayer Revenue in Advanced Drug Delivery Business (2018-2023)
11.5.5 Bayer Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Advanced Drug Delivery Introduction
11.6.4 Sanofi Revenue in Advanced Drug Delivery Business (2018-2023)
11.6.5 Sanofi Recent Developments
11.7 Glaxosmithkline
11.7.1 Glaxosmithkline Company Details
11.7.2 Glaxosmithkline Business Overview
11.7.3 Glaxosmithkline Advanced Drug Delivery Introduction
11.7.4 Glaxosmithkline Revenue in Advanced Drug Delivery Business (2018-2023)
11.7.5 Glaxosmithkline Recent Developments
11.8 3M
11.8.1 3M Company Details
11.8.2 3M Business Overview
11.8.3 3M Advanced Drug Delivery Introduction
11.8.4 3M Revenue in Advanced Drug Delivery Business (2018-2023)
11.8.5 3M Recent Developments
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Advanced Drug Delivery Introduction
11.9.4 Pfizer Revenue in Advanced Drug Delivery Business (2018-2023)
11.9.5 Pfizer Recent Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Advanced Drug Delivery Introduction
11.10.4 Johnson & Johnson Revenue in Advanced Drug Delivery Business (2018-2023)
11.10.5 Johnson & Johnson Recent Developments
11.11 Abbott Laboratories
11.11.1 Abbott Laboratories Company Details
11.11.2 Abbott Laboratories Business Overview
11.11.3 Abbott Laboratories Advanced Drug Delivery Introduction
11.11.4 Abbott Laboratories Revenue in Advanced Drug Delivery Business (2018-2023)
11.11.5 Abbott Laboratories Recent Developments
11.12 Allergan
11.12.1 Allergan Company Details
11.12.2 Allergan Business Overview
11.12.3 Allergan Advanced Drug Delivery Introduction
11.12.4 Allergan Revenue in Advanced Drug Delivery Business (2018-2023)
11.12.5 Allergan Recent Developments
11.13 Baxter International
11.13.1 Baxter International Company Details
11.13.2 Baxter International Business Overview
11.13.3 Baxter International Advanced Drug Delivery Introduction
11.13.4 Baxter International Revenue in Advanced Drug Delivery Business (2018-2023)
11.13.5 Baxter International Recent Developments
11.14 Mylan Pharmaceutical
11.14.1 Mylan Pharmaceutical Company Details
11.14.2 Mylan Pharmaceutical Business Overview
11.14.3 Mylan Pharmaceutical Advanced Drug Delivery Introduction
11.14.4 Mylan Pharmaceutical Revenue in Advanced Drug Delivery Business (2018-2023)
11.14.5 Mylan Pharmaceutical Recent Developments
11.15 Roche Holding
11.15.1 Roche Holding Company Details
11.15.2 Roche Holding Business Overview
11.15.3 Roche Holding Advanced Drug Delivery Introduction
11.15.4 Roche Holding Revenue in Advanced Drug Delivery Business (2018-2023)
11.15.5 Roche Holding Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Merck & Co
Antares Pharma
F. Hoffmann-La Roche
Novartis
Bayer
Sanofi
Glaxosmithkline
3M
Pfizer
Johnson & Johnson
Abbott Laboratories
Allergan
Baxter International
Mylan Pharmaceutical
Roche Holding
听
听
*If Applicable.
